Skip to main content
●+254 119 023975 support@dnalabskenya.com
Patient Portal LoginB2B / Doctor Portal
DNA LabsKenya
Medical information Clinical review pending

Transplant Testing

HLA DR Class II Typing Test

The HLA DR Class II Typing Test assesses compatibility between organ donors and recipients, crucial for successful transplantation. Helps determine the best match to reduce rejection risk.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
4 mL (3 mL minimum) whole blood in 1 Lavender Top (EDTA) tube OR 6 mL (3 mL minimum) whole blood in 1 Yellow Top (ACD) tube.
Results
10-12 days
Preparation
No special preparation is required. A doctor's prescription on letterhead with photos of recipient and donor (stamped) and a signed Consent form for HLA Typing for Solid organ transplant (Form 33) are mandatory.
Test priceKSh 17,316

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the HLA DR Class II Typing Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us
01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Patients awaiting organ transplantation (kidney, liver, heart, etc.).
  • ✓Individuals referred by transplant specialists.
  • ✓Patients needing assessment for donor compatibility.
  • ✓Family members potentially involved in living organ donation.
02

In plain language

What this test helps you understand

This test is used to determine the compatibility between potential organ donors and recipients, aiming to minimize the risk of transplant rejection and improve long-term graft survival.
The HLA DR Class II Typing Test is a vital diagnostic tool used to assess compatibility between organ donors and recipients. This test plays a crucial role in the field of transplantation, ensuring that patients receive the best possible match for organ transplants. Understanding HLA typing is essential for preventing transplant rejection and enhancing the success rates of procedures. This test detects specific genetic markers known as Human Leukocyte Antigens (HLAs) that are present on the surface of white blood cells. These markers are critical in determining whether a transplanted organ will be accepted or rejected by the recipient's immune system. Results from the HLA DR Class II Typing Test will indicate the compatibility of the donor and recipient. A close match increases the likelihood of transplant success. It is essential to discuss the results with your healthcare provider to understand their implications fully.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required. A doctor's prescription on letterhead with photos of recipient and donor (stamped) and a signed Consent form for HLA Typing for Solid organ transplant (Form 33) are mandatory.
Sample4 mL (3 mL minimum) whole blood in 1 Lavender Top (EDTA) tube OR 6 mL (3 mL minimum) whole blood in 1 Yellow Top (ACD) tube.
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test specifically types for HLA DR Class II alleles. Compatibility assessment often involves typing for other HLA loci as well. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test identifies specific genetic markers (HLA DR Class II) on white blood cells to assess compatibility between organ donors and recipients.
It helps determine how well a donor organ will match the recipient's immune system, reducing the risk of rejection and improving transplant success.
Patients preparing for organ transplants (like kidney, liver, or heart) typically need this test to find the best donor match.
A blood sample is required. Specific tube types (Lavender or Yellow Top) and volumes are needed.
Results are typically available within 10-12 days.
No special preparation is needed for the blood draw itself, but specific documentation (doctor's prescription, consent form, photos) is required.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chimerism Split Cell Analysis T Cell CD3 Test

Monitors post-transplant recovery by measuring the proportion of donor and recipient T cells (CD3 positive) in the blood or bone marrow. Essential for assessing graft acceptance or rejection after hematopoietic stem cell transplantation.

Learn more →

HLA ABC Class 1 Typing Test

The HLA ABC Class 1 Typing Test helps determine compatibility between organ donors and recipients, crucial for successful transplantation.

Learn more →

HLA AB Class 1 Typing Test

The HLA AB Class 1 Typing Test helps determine compatibility between organ donors and recipients, crucial for successful kidney, liver, or heart transplants. This test identifies specific antigens to minimize organ rejection risk.

Learn more →

HLA DP Typing Test

The HLA DP Typing Test helps determine compatibility between organ donors and recipients, crucial for successful transplantation. It assesses specific human leukocyte antigens (HLA) to minimize rejection risk.

Learn more →
Chat on WhatsApp